BAYER SCHWEIZ AG - Switzerland 

This institution has been merged with: BAYER.

Ranking results:

Past rankings:

2010
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2010 0 13.761.555 276.532 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
BAYER2
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN2
VTT TECHNICAL RESEARCH CENTRE OF FINLAND2
CEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
DEUTSCHES KREBSFORSCHUNGSZENTRUM1
F HOFFMANNLA ROCHE1
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III1
GENENTECH INC1
INSTITUT CURIE1
ONCOMARK LIMITED1
PATHOLOGY EXPERTS1
RHEINISCHE FRIEDRICHWILHELMSUNIVERSITAT BONN1
ROYAL COLLEGE OF SURGEONS IN IRELAND1
ST ANNA KINDERKREBSFORSCHUNG1
STICHTING VU1
THE UNIVERSITY OF WARWICK1
UNIVERSITAET BERN1
UNIVERSITAETSKLINIKUM ESSEN1
UNIVERSITEIT GENT1
UNIVERSITY COLLEGE LONDON1
UNIVERSITY OF COPENHAGEN1
VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG1
WEIZMANN INSTITUTE OF SCIENCE1

Constancy:

Total number of partners: 27
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 27
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2010-11-01ASSET: Analysing and Striking the Sensitivities of Embryonal Tumours ASSETparticipant11.999.15619
2010-07-01Histopathologic and Mechanistic Assessment of Angiogenesis Inhibitor Related Toxicities: A Cross-Sectoral, Multi-disciplinary Approach ANGIOTOXparticipant1.762.39910